The number of cell clones in the KYSE150 control group was significantly and markedly higher than those in the sh-Ezrin group (P = 0.004), demonstrating that Ezrin can boost ESCC cell proliferation (Figure 5). Here, EZR is linked to esophageal squamous cell carcinoma.